Hennion & Walsh Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
36,169
-540
| -1% | -$23.3K | 0.06% | 367 |
|
|
2025
Q1 | $1.27M | Sell |
36,709
-950
| -3% | -$32.8K | 0.06% | 414 |
|
|
2024
Q4 | $1.03M | Sell |
37,659
-384
| -1% | -$10.5K | 0.05% | 462 |
|
|
2024
Q3 | $969K | Sell |
38,043
-1,056
| -3% | -$26.9K | 0.05% | 455 |
|
|
2024
Q2 | $990K | Sell |
39,099
-104,995
| -73% | -$2.66M | 0.05% | 422 |
|
|
2024
Q1 | $4.46M | Buy |
144,094
+22,441
| +18% | +$694K | 0.24% | 95 |
|
|
2023
Q4 | $4.91M | Buy |
121,653
+33,672
| +38% | +$1.36M | 0.28% | 74 |
|
|
2023
Q3 | $2.32M | Buy |
87,981
+3,494
| +4% | +$92.1K | 0.15% | 185 |
|
|
2023
Q2 | $1.45M | Sell |
84,487
-2,276
| -3% | -$39.1K | 0.09% | 286 |
|
|
2023
Q1 | $1.44M | Sell |
86,763
-2,742
| -3% | -$45.5K | 0.09% | 277 |
|
|
2022
Q4 | $682K | Buy |
89,505
+11,152
| +14% | +$85K | 0.04% | 423 |
|
|
2022
Q3 | $779K | Buy |
78,353
+19,508
| +33% | +$194K | 0.05% | 386 |
|
|
2022
Q2 | $534K | Buy |
+58,845
| New | +$534K | 0.03% | 468 |
|